NanoViricides announces pricing of ~$2M registered direct offering
Source: SeekingAlpha
2026-05-15 08:48:43 ET
More on NanoViricides
- NanoViricides GAAP EPS of -$0.09
- Seeking Alpha’s Quant Rating on NanoViricides
- Historical earnings data for NanoViricides
- Financial information for NanoViricides
Read the full article on Seeking Alpha
For further details see:
NanoViricides announces pricing of ~$2M registered direct offering
NanoViricides Inc.
NASDAQ: NNVC
NNVC Trading
-4.79% G/L:
$1.4947 Last:
137,962 Volume:
$1.53 Open:
NNVC Latest News
May 26, 2026 10:05:00 am
MissionIRNewsBreaks - NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Candidate for Bundibugyo Ebola Outbreak
May 26, 2026 08:30:00 am
In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides
NNVC Stock Data
$21,253,530
20,791,966
19.1%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Shelton
